News

Using generic PrEP bought online – new guide for how to use PrEP safely, including options for dosing…

Introduction This year the biennial Glasgow conference was held from 23-26 October 2016. The meeting has a single-track programme making it easy to attend and follow the whole programme, often highlight important European research before it is presented at CROI, …

First reports from this prevention conference being held in Chicago.

PrEP safety, side effects of integrase inhibitors, HIV and children and global access to dolutegravir – reports from four meetings + other news including reduced dose maintenance studies…

This is a small selection of work that was included in a major art exhibition about HIV – either from artists who were/are HIV positive or from other artists responding to the AIDS crisis. The exhibition included about 300 individual …

News from Durban on HIV prevention including TasP and PrEP, paediatrics, TB and cure research – plus news about PrEP in the UK…

Reports from AIDS 2016 include PrEP and new drugs plus news from the pre-conference paediatric and TB workshops…

Simon Collins, HIV i-Base On 29 July 2016, the PROUD study website announced that the study will close without being able to continue to provide participants with oral PrEP. [1] The press release blames NHS England for cancelling the previous …

Simon Collins, VIH i-Base Los resultados del estudio PARTNER publicados en coincidencia con la conferencia AIDS 2016, que se inaugura en Durban (Sudáfrica) la próxima semana, revelan el impacto del tratamiento antirretroviral en la drástica reducción de la transmisión del …

NOTE: For later pipeline reports produced as the i-Base Fit For Purpose publications please see: https://i-base.info/hiv-pipeline-reports-2010-2019 From 2010 – 2016,  i-Base collaborated with Treatment Action Group (TAG) to produce an annual review of latest research. Since 2017, i-Base produce separate …

El siguiente cuestionario está relacionado con el estudio PARTNER que fue publicado en la edición del 12 de julio de 2016 de Journal of the American Medical Association (JAMA), cuya versión completa está disponible de forma gratuita. A continuación se …

Full paper published in JAMA as open access article.

Annual overview of HIV and TB pipeline research: paediatrics and adults

The following letter was sent to Public Health England (PHE) in response to being asked to join a community advisory board for proposed further PrEP research. There are important questions about PrEP but this proposed study is looking at none …

One of the most significant and healthy changes over the last year has been the new energy and activism over HIV prevention work – and for the UK this is particularly notable.  Much of this has been focused on PrEP …

NHS decision to block PrEP, reports from BHIVA, EASL, CROI and HIV and Women conferences, use of HPV vaccine – and remembering i-Base founder Paul Blanchard…

This post is about two open meetings I attended this month at the United Nations as part of preparations for the upcoming UN High Level Meeting on HIV/AIDS in June 2016. These meetings were for community input into the next …

Optimistic news suggests that UK access to PrEP may still be considerd in June, following a threat of legal action against NHS England for their decision terminate public discussion on a stakeholder report that had recommended approval. On 19 April …

Simon Collins, HIV i-Base The dominant market structure where pharmaceutical drug pricing blocks access to otherwise cheap-to-manufacture life-saving medicines from the people who most need them, was highlighted by international activists on Friday. This was a coordinated action linking community-based …

The dominant market structure where pharmaceutical drug pricing blocks access to otherwise cheap-to-manufacture life-saving medicines from the people who most need them, was highlighted by international activists on Friday. This was a coordinated action linking community-based organisations from seven countries …